Skip to main content

MetLife Investment Management, LLC

Position in FLGT — Fulgent Genetics, Inc.

CIK 1529735 Whippany, NJ

Position in FLGT

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$200,006
-$130,444 QoQ
Shares Held
12,579
0.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in FLGT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

MetLife Investment Management, LLC holds $161,378,137 across 30 Diagnostics & Research names. FLGT ranks #29 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FLGT

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $200,006 12,579
2025-12-31 $330,450 12,579
2025-09-30 $284,285 12,579
2025-06-30 $250,070 12,579
2025-03-31 $217,249 12,855
2024-12-31 $237,431 12,855
2024-09-30 $279,339 12,855
2024-06-30 $252,215 12,855
2024-03-31 $255,105 11,756
2023-12-31 $339,865 11,756
2023-09-30 $314,355 11,756
2023-06-30 $435,324 11,756
2023-03-31 $367,022 11,756
2022-12-31 $350,093 11,756
2022-09-30 $448,138 11,756
2022-06-30 $641,054 11,756
2022-03-31 $733,691 11,756
2021-12-31 $746,076 7,417
2021-09-30 $667,159 7,417
2021-06-30 $684,069 7,417
2021-03-31 $488,220 5,053
2020-12-31 $263,261 5,053
2020-09-30 $202,322 5,053